PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-3420

  1. 515 Posts.
    lightbulb Created with Sketch. 43
    “Unapproved injectable formulations of pentosan have a long history of use in horses, but the newly approved therapy is the first injectable pentosan product to have met the FDA’s standards. FDA-approved drugs have been demonstrated to be safe and effective for their intended use and have been consistently manufactured to preserve the drugs’ identity, strength, quality, and purity. The FDA is strongly encouraging veterinarians to use the legally marketed FDA-approved pentosan polysulfate sodium injection when pentosan is indicated for use in an equine patient.”
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.